Pluri (PLUR) Equity Ratio (2011 - 2025)

Pluri (PLUR) reported Equity Ratio of 0.3 for Q4 2025, down 218.57% year-over-year from 0.25 in Q4 2024, and down 79.55% quarter-over-quarter from 0.17 in Q3 2025.

Pluri (PLUR) Equity Ratio (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 15 years of Equity Ratio data on file, last reported at 0.3 in Q4 2025.

  • Equity Ratio for Q4 2025 came in at 0.3, down 218.57% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.3 (down 218.57% YoY), and the FY2025 annual result was 0.18, down 229.11% from the prior year.
  • Equity Ratio eased to 0.3 in Q4 2025 per PLUR's latest filing, from 0.17 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.86 in Q1 2021 and troughed at 0.3 in Q4 2025.
  • A 5-year average of 0.24 and a median of 0.27 in 2023 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2021 and 2025: Equity Ratio jumped 39.82% in 2021, then slumped 9334.67% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.49 in 2021, then declined by 15.11% to 0.42 in 2022, then plunged by 61.79% to 0.16 in 2023, then plunged by 159.37% to 0.09 in 2024, then plunged by 218.57% to 0.3 in 2025.
  • Business Quant data shows PLUR's Equity Ratio at 0.3 in Q4 2025, 0.17 in Q3 2025, and 0.18 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 191.07
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 0.98
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 0.04
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.58
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 0.42
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 0.73
9 Abivax 94.37 Bn 94.37 Bn - 0.79
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -0.30

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.30
Sep 30, 2025 -0.17
Jun 30, 2025 -0.18
Mar 31, 2025 -0.12
Dec 31, 2024 -0.09
Sep 30, 2024 0.00
Jun 30, 2024 0.14
Mar 31, 2024 0.05
Dec 31, 2023 0.16
Sep 30, 2023 0.25
Jun 30, 2023 0.30
Mar 31, 2023 0.37
Dec 31, 2022 0.42
Sep 30, 2022 0.45
Jun 30, 2022 0.47
Mar 31, 2022 0.51
Dec 31, 2021 0.49
Sep 30, 2021 0.58
Jun 30, 2021 0.61
Mar 31, 2021 0.86